Profile

Christopher A. Ohl, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

55 Ratings
3 Comments
 

Christopher A. Ohl, M.D.

Professor,

Clinical Interests

Infectious Diseases, Antimicrobial Utilization and Impact on Clinical Outcomes, Antimicrobial Resistance

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-2700
Department: 336-716-4507

Insurance Accepted »

Additional Languages

Japanese

Education & Training

  • B.S., University of Wisconsin-Eau Claire, 1982
  • M.D., University of Wisconsin Medical School, 1986
  • Internship, Internal Medicine, National Naval Med Ctr, 1987
  • Residency, Internal Medicine, National Naval Med Ctr, 1992
  • Fellowship, Infectious Disease, National Naval Med Ctr, 1994

Board Certifications

  • American Board of Internal Medicine, Infectious Disease
  • American Board of Internal Medicine, Internal Medicine

Memberships

  • Am Coll Of Physicians
  • Am Medical Assn
  • Infectious Disease Soc of Amer

NPI Number

  • 1619952991
Christopher A. Ohl, M.D.

Doctor Rating

4.8 out of 5

55 Ratings
3 Comments
 

Christopher A. Ohl, M.D.

Professor, Infectious Diseases

Contact Information

Academic: 336-716-2700 | Department: 336-716-4507

Recent Publications

Williamson JC, Gibbs HG, Ohl CA, Johnson JW, Beardsley JR, Luther VP, Rokas KE. Reply to Young, Ochi, and Marimuthu [letter]. Clin Infect Dis. 2016;62(6):810-811.

Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-e77.

Rokas KE, Johnson JW, Beardsley JR, Ohl CA, Luther VP, Williamson JC. The addition of intravenous metronidazole to oral vancomycin is associated with improved mortality in critically ill patients with Clostridium difficile Infection. Clin Infect Dis. 2015;61(6):934-941.

Schwartz BS, Armstrong WS, Ohl CA, Luther VP. Create allies, IDSA stewardship commitments should prioritize health professions learners [letter]. Clin Infect Dis. 2015;61(10):1626-1627.

Ohl CA, Luther VP. Health care provider education as a tool to enhance antibiotic stewardship practices. Infect Dis Clin North Am. 2014;28(2):177-193.

Palmer HR, Palavecino EL, Johnson JW, Ohl CA, Williamson JC. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia. Eur J Clin Microbiol Infect Dis. 2013;32(7):955-959.

Chittick P, Williamson JC, Ohl CA. BK virus encephalitis: case report, review of the literature, and description of a novel treatment modality. Ann Pharmacother. 2013;47(9):1229-1233.

Luther VP, Ohl CA, Hicks LA. Antimicrobial stewardship education for medical students [letter]. Clin Infect Dis. 2013;57(9):1366.

Koliscak LP, Johnson JW, Beardsley JR, Miller DP, Williamson JC, Luther VP, Ohl CA. Optimizing empiric antibiotic therapy in patients with severe beta-lactam allergy. Antimicrob Agents Chemother. 2013;57(12):5918-5923.

Beardsley JR, Williamson JC, Johnson JW, Luther VP, Wrenn RH, Ohl CC. Show me the money: long-term financial impact of an antimicrobial stewardship program. Infect Control Hosp Epidemiol. 2012;33(4):398-400.

Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med. 2011;6(Suppl 1):S4-S15.

Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis. 2011;53(Suppl 1):S23-S28.

Ohl CA. Infectious arthritis of native joints In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases, vol 1. 7th ed. Philadelphia: Churchill Livingstone/Elsevier;2010: 1443-1456.

Luther VP, Bookstaver PB, Ohl CA. Corticosteroids in the treatment of hepatic tuberculosis: case report and review of the literature. Scand J Infect Dis. 2010;42(2):315-317.

Paddock CD, Finley RW, Wright CS, Robinson HN, Schrodt BJ, Lane CC, Ekenna O, Blass MA, Tamminga CL, Ohl CA, et al. Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Infect Control Hosp Epidemiol. 2008;29(Suppl 1):1188-1196.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA. Controlling prescription drug expenditures: a report of success. Am J Manag Care. 2007;13(8):473-480.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA. Controlling prescription drug expenditures: a case report of success [abstract]. J Gen Intern Med. 2007;22(Suppl 1):64.

Luther VP, Smith ZE, Varela V, Williamson JC, Karchmer TB, Palavecino E, Ohl CA. Risk factors for invasive infection due to cephalosporin resistant enterobacter [abstract]. In: Proceedings of the 17th Annual Meeting of the Society for Healthcare Epidemiology of America; 2007 Apr 14-17; Baltimore (MD). 2007;():a252.5.

Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest. 2006;130(3):787-793.

Ohl C. Epidemiology of pneumococcal disease and efficacy of polysaccharide vaccines in adults [abstract]. 12th International Conference on Infectious Diseases Abstract Book. 2006;():S232-S233.

Ganatra V, Williamson J, Johnson J, Beardsley J, Karchmer TB, Ohl CA. Improper pre-cision timing of vancomycin prophylaxis in patients undergoing CAG, laminectomy and total joint replacement [abstract]. In: 44th Annual Meeting of the Infectious Diseases Society of America Abstracts; 2006 Oct 12-15; Toronto (Canada). 2006;():85.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Infectious Diseases

Clinical Interests

Infectious Diseases, Antimicrobial Utilization and Impact on Clinical Outcomes, Antimicrobial Resistance
Christopher A. Ohl, M.D.

Christopher A. Ohl, M.D.

Professor, Infectious Diseases

Doctor Rating

4.8 out of 5

Christopher A. Ohl, M.D.55 Ratings
3 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.9
CP explanations of prob/condition
4.8
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
4.5



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

1/1/2016

I'm extremely confident in Dr. Ohl medical advice. He gave me the best advice in his expertise in ID, and knew when to encourage me to speak to another physician for the best information in matters that would be handled best by another specialist.

8/25/2015

Exceptional.

8/7/2015

Best travel doc I've seen!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.